All In Biotech

Drug Trial Radar · NCT00326612

Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures

Intranasal Midazolam Versus Rectal Diazepam for the Home Treatment of Seizure Activity in Pediatric Patients With Epilepsy

Last checked: Nov 19, 2026Latest source record: Oct 26, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 358 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

358

Actual

Start

Jun 2006

Primary completion

Dec 2008

Study completion Dec 2008

Sponsor

Lead sponsor
University of UtahAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Primary Children's Hospital
First posted
May 17, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 1 week, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The investigators will conduct a randomized controlled trial comparing the use of nasal midazolam, using a Mucosal Atomization Devise, to rectal diazepam for the treatment of acute seizure activity in children under the age of 18 years with epilepsy in the community setting. The primary hypothesis is that nasal midazolam will be more effective and have shorter seizure time compared to rectal diazepam in the community. The secondary hypotheses are that patients treated with nasal midazolam will have fewer respiratory complications, emergency department visits, and admissions.

Conditions

  • Seizures

Interventions

  • MidazolamDrug

    Intranasal Midazolam 0.2 mg/kg given once for seizures longer than 5 minutes.

  • DiazepamDrug

    Rectal Diazepam (Diastat) given once for seizure greater than 5 minutes.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Length of Seizure After Study Medication AdministrationTime frame: 24 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Primary Children's Medical Center

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.